To unsubscribe from updates about LYTGOBI® (futibatinib) tablets, please complete the following form:All fields are mandatory unless otherwise noted. Email Address Select the type(s) of communication you would like to unsubscribe from: LYTGOBI® emails from Taiho Oncology (including clinical information, news and announcements) LYTGOBI® emails from your Taiho Representative (including appointment bookings, follow-ups, and clinical information) All LYTGOBI® Emails